王者荣耀比赛赛程

Dexcom traded at $92.89 this Friday September 9th, increasing $1.30 or 1.42 percent since the previous trading session. Looking back, over the last four weeks, Dexcom gained 3.52 percent. Over the last 12 months, its price fell by 32.37 percent. Looking ahead, we forecast Dexcom to be priced at 79.64 by the end of this quarter and at 72.95 in one year, according to 王者荣耀电竞(江西)积分排榜 global macro models projections and analysts expectations.

Stock Price
92.89
Daily Change
1.42%
Yearly
-32.37%

Ok
王者荣耀电竞(江西)积分排榜 members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The 王者荣耀电竞(江西)积分排榜 Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Abiomed 282.28 6.71 2.44% -21.85%
Abbott 108.48 1.49 1.39% -15.78%
Align Technology 263.11 5.81 2.26% -63.49%
AtriCure 46.45 1.20 2.65% -37.80%
Avanos Medical Inc 25.42 0.67 2.71% -19.20%
Baxter International 59.53 0.83 1.41% -26.43%
Becton, Dickinson and Co. 262.85 2.35 0.90% 1.75%
Boston Scientific 42.94 0.23 0.54% -3.42%
Cooper Companies 314.70 6.80 2.21% -30.28%
Cardiovascular Systems 14.13 0.11 0.78% -59.91%
Dexcom 92.89 1.30 1.42% -32.37%
Edwards Lifesciences 97.25 1.73 1.81% -19.56%
Globus Medical 62.81 1.72 2.82% -22.89%
Hologic 69.16 0.29 0.42% -13.54%
Integra LifeSciences 49.59 1.14 2.35% -29.39%
Inogen 27.39 -0.05 -0.18% -44.72%
J&J 165.71 0.32 0.19% -0.75%
Masimo 156.25 2.24 1.45% -43.05%
Medtronic 89.73 1.84 2.09% -31.58%
Merit Medical Systems 61.45 0.41 0.67% -14.30%
NuVasive 46.65 0.46 1.00% -19.15%
Insulet 268.91 -0.72 -0.27% -9.28%
Roche Holding 324.25 0.40 0.12% -5.74%
Sientra 0.64 0.03 4.07% -89.79%
Stryker 230.00 9.72 4.41% -16.02%
Teleflex 242.15 4.69 1.98% -34.98%
Tandem Diabetes Care 55.98 3.37 6.41% -54.36%
West Pharmaceutical Services 313.51 5.38 1.75% -31.70%
Zimmer Biomet Holdings Inc 114.50 3.71 3.35% -18.47%

Indexes Price Day Year
USND 12112 250.18 2.11% -19.87%
US2000 1883 35.94 1.95% -15.47%
US500 4067 61.18 1.53% -8.77%
USNDX 12588 267.10 2.17% -18.47%

Dexcom
Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.